News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Daily News Radial Access Best for PCI Following Thrombolysis in STEMI Michael O'Riordan November 27, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Daily News Even Mild Exercise May Reduce Mortality in Stable CAD L.A. McKeown September 27, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Daily News Extended Low-Dose Ticagrelor May Prevent Adverse Events Post-MI, Study Finds Yael L. Maxwell September 12, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared Todd Neale August 15, 2017
News Daily News Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests Michael O'Riordan August 14, 2017
News Conference News SCCT 2017 Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration Yael L. Maxwell July 09, 2017
News Daily News More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis Michael O'Riordan July 03, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction Yael L. Maxwell March 03, 2017